Skip to main content

CORRECTION article

Front. Cell. Infect. Microbiol.
Sec. Clinical Microbiology
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1558708

Corrigendum: Editorial: Antiviral monoclonal antibody therapies

Provisionally accepted
Catalina Florez Catalina Florez 1,2*Denise Haslwanter Denise Haslwanter 3*Rohit K Jangra Rohit K Jangra 4*
  • 1 The Henry M. Jackson Foundation, Bethesda, MD, United States
  • 2 U.S Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States
  • 3 Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United States
  • 4 Department of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, United States

This article is a correction to:

  1. Editorial: Antiviral Monoclonal Antibody Therapies

    1. Read original article

The final, formatted version of the article will be published soon.

    Incorrect Funding In the published article, there was an error in the Funding statement. The NIH support for Rohit K Jangra (R.K.J.) is missing. The correct Funding statement appears below.FUNDINGThis work was partly supported by grants (R21AI156482 and P20GM134974 to R.K.J.) from the National Institutes of Health, USA.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

    Keywords: Monoclonal Abs, antiviral, SARS-CoV-2, COVID, bispecific Ab

    Received: 10 Jan 2025; Accepted: 13 Jan 2025.

    Copyright: © 2025 Florez, Haslwanter and Jangra. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Catalina Florez, The Henry M. Jackson Foundation, Bethesda, MD, United States
    Denise Haslwanter, Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United States
    Rohit K Jangra, Department of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.